Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/19/12 → 10/19/18 |
Funding
- AVEO Pharmaceuticals, Inc. (Prot #AV-951-12-205)
Prot #AV-951-12-205: A Phase 2 Randomized, Double-Blind, Crossover, Controlled, Multi-Center, Subject Preference Study of Tivozanib Hydrochloride Versus Sunitinib in the Treatment of Subjects with Metastatic Renal Cell Carcinoma
- Kuzel, Timothy Michael (PD/PI)
Project: Research project